Milk Thistle
Effects On Enzymes And Transporters
UGT Enzyme | Effects | Strength | Dosage | Verified in Man |
---|---|---|---|---|
UGT1A1 | No Effect1 [5] | ? | 200 mg 3 times a day | Yes |
UGT1A6 | Inhibition [2] | IC50 59.5 μg/ml | ? | ? |
UGT1A9 | Inhibition [2] | IC50 33.6 μg/ml | ? | ? |
UGT2B7 | Inhibition [3] | ? | ? | ? |
P450 Enzyme | Effects | Strength | Dosage | Verified in Man |
CYP2C9 | Inhibition and possible induction2 | ? | ? | ? |
CYP2D6 | No effect [1] | ? | ? | Yes |
CYP3A4 | No effect [5] | ? | 200 mg 3 times a day | Yes |
Transporter | Effects | Strength | Dosage | Verified in Man |
P-Glycoprotein (Pgp) | Inhibition [4] | ? | ? | ? |
Bibliography
1. Clinical assessment of CYP2D6-mediated herb-drug interactions in humans: effects of milk thistle, black cohosh, goldenseal, kava kava, St. John's wort, and Echinacea.
Gurley BJ, Swain A, Hubbard MA, Williams DK, Barone G, Hartsfield F, Tong Y, Carrier DJ, Cheboyina S, Battu SK; PubMed PMID 18214849
2. Inhibitory effects of commonly used herbal extracts on UDP-glucuronosyltransferase 1A4, 1A6, and 1A9 enzyme activities.
Mohamed ME, Frye RF. PubMed: PMID: 21632963
3. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies.
Mohamed ME, Frye RF. PubMed: PMID: 21049395
4. Emerging Significance of Flavonoids as P-Glycoprotein Inhibitors in
Cancer Chemotherapy Tripta Bansal, Manu Jaggi, Roop K Khar and Sushama Talegaonkar; J Pharm Pharmaceut Sci (www. cspsCanada.org) 12 (1): 46 - 78, 2009 (Download Attached PDF Document)
5. Effect of milk thistle (Silybum marianum) on the pharmacokinetics of irinotecan.
van Erp NP, Baker SD, Zhao M, Rudek MA, Guchelaar HJ, Nortier JW, Sparreboom A, Gelderblom H. PubMed PMID: 16278402page revision: 6, last edited: 02 Feb 2013 23:44